Re: Fw: Health News: [Sprycel]

[Guest guest]

I for one are glad we have these drugs...and recognize that further

research requires the companies who make them to make a profit. Does anyone

want

to go back 15 years and deal with the death watch we would all be on

without them?

Tom in KY

In a message dated 9/25/2010 10:18:59 A.M. Eastern Daylight Time,

ctdavies2003@... writes:

I found this article very instructive regarding the " business " of leukemia.

We

are all participants in the for profit leukemia " market. " The extremely

overpriced leukemia drugs that we are forced to take in order to stay

alive are

profit centers for large corporations. We are profit centers assuming we

in the

U.S. are lucky enough to have access to Gleevec, Spryce, Tasigna, etc.

Has anyone given serious thought to our system that allows corporations to

profit from our misery???

Health News Alert

Alerts Health - My Alerts - Edit Alert

Friday, September 24, 2010 5:12 PM PDT

Sponsored Link

Special Offer - Free Trial of Blockbuster.com

Rent Movies from Blockbuster.com. Delivered Direct To Your Mailbox.

Click here to start today.

www.Blockbuster.com

Drug Sales In The Leukemia Market Will Be Driven By Therapies From

Novartis,

Bristol-Myers Squibb, Biogen Idec, Roche ...

Medical News Today Fri, 24 Sep 2010 09:18 AM PDT

Decision Resources, one of the world's leading research and advisory firms

for

pharmaceutical and healthcare issues, finds that growth in the leukemia

market

will be driven mostly by chronic myelogenous leukemia (CML) therapies

(Novartis's Gleevec and Tasigna and Bristol-Myers Squibb's Sprycel) and

chronic

lymphocytic leukemia (CLL) therapies (Biogen Idec/Roche's Rituxan and

Cephalon's

Treanda ...

See more health stories that match my keyword

Visit Health

________________________________

You received this email because you subscribed to Alerts. Use this

link

to unsubscribe from this alert. To change your communications preferences

for

other business lines, please visit your Marketing Preferences. To

learn

more about 's use of personal information, including the use of web

beacons in HTML-based email, please read our Privacy Policy. is

located

at 701 First Avenue, Sunnyvale, CA 94089.

[Non-text portions of this message have been removed]

[Guest guest]

>

> I for one are glad we have these drugs...and recognize that further

> research requires the companies who make them to make a profit. Does anyone

want

> to go back 15 years and deal with the death watch we would all be on

> without them?

> Tom in KY

________________________

Hi Tom,

The problem is that the drug company did not pay for MUCH of the

research......the federal govt did with grants, etc. Also the L & L Society and

some Universities. If the drug companies HAD to pay back the govt. for the

grants if a successful drug was developed, that would make this arrangement more

fair.

You only have to look at the profits these companies are making and the salaries

and bonuses of their CEOs to see that the price is a rip off. There has been

much in writing about the amount that the drug companies are spending on

advertising vs research....and they are spending MUCH more on advertising! If

you have the only drug in town (or one of 3) that can treat a fatal disease and

have a patent, you pretty much can charge whatever you can get away with.

C.

[Guest guest]

>

> Hi, I am also glad we have these new drugs, and thankful for the pharm, that

produce them. BUT, about trials, I have a question.  I have been in 6 trials in

10 years.  You all know that means , in the beginning a bma/bmb monthly, if

things go the way they should, that goes to quarterly.  As long as I can

remember, I  get labs done every single week. To say nothing of a zillion ekgs,

echo cardiograms, meds to take care of side effects, etc, etc., etc.,  The drug

companies involved have not paid one dime of these expenses, it is all paid for

by medicare and AARP. Nor have I paid one dime.

_______________________________

Hi Bobby,

I definitely know what you mean. The drug company, when you are in a trial, says

that they don't pay for 'normal' parts of cml care.....but without being in a

trial, NO ONE whould have a bmb/bma every 3 months!! that is not standard care.

These days, unless you are newly dx, you might have a bmb once a year or less.

I think a different way to look at it is.....if the drug company did not think

they had a chance to make buco bucks from a new drug, then they would not

bother. That is there big incentive?

It is a quite a bit different, when a scientist like Dr. Druker (or Dr. Talpaz

in his research) is developing a drug in the lab, often with samples from a drug

company......it is the University or research hospital that is paying for a lot

of the development of the drug, and financial gain is NOT the primary incentive.

Dr. Druker is not in his lab (now working on targeted drugs for other leukemias)

because he is going to get rich by doing it. But if a new drug is developed,

some drug company will make some big profits.

C.